ADDYI Drug Patent Profile
✉ Email this page to a colleague
When do Addyi patents expire, and what generic alternatives are available?
Addyi is a drug marketed by Sprout Pharms and is included in one NDA. There are two patents protecting this drug.
This drug has forty-two patent family members in twenty-nine countries.
The generic ingredient in ADDYI is flibanserin. One supplier is listed for this compound. Additional details are available on the flibanserin profile page.
DrugPatentWatch® Generic Entry Outlook for Addyi
Addyi was eligible for patent challenges on August 18, 2019.
Indicators of Generic Entry
Summary for ADDYI
International Patents: | 42 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Patent Applications: | 346 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ADDYI |
What excipients (inactive ingredients) are in ADDYI? | ADDYI excipients list |
DailyMed Link: | ADDYI at DailyMed |


Pharmacology for ADDYI
Mechanism of Action | P-Glycoprotein Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ADDYI
US Patents and Regulatory Information for ADDYI
ADDYI is protected by two US patents.
Patents protecting ADDYI
Method of treating female hypoactive sexual desire disorder with flibanserin
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
Treating sexual desire disorders with flibanserin
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ADDYI
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ADDYI
See the table below for patents covering ADDYI around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Croatia | P20040107 | STABILNI POLIMORF FLIBANSERINA, TEHNIČKI POSTUPAK NJEGOVA PRIPRAVLJANJA, TE NJEGOVA PRIMJENA U PROIZVODNJI LIJEKOVA (STABLE POLYMORPH OF FLIBANSERIN, TECHNICAL PROCESS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS) | ⤷ Try a Trial |
Montenegro | P42808 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 03014079 | ⤷ Try a Trial | |
China | 102125557 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |